# A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

> **NCT07654972** · PHASE1 · RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 108 (estimated)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** LY4174794
- **DRUG:** LY4174794
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07654972
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-24
- **Primary completion:** 2029-04
- **Final completion:** 2029-04
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2026-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07654972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07654972, "A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07654972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*